Top

Published in:

Open Access 01-07-2020 | Letter to the Editors

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease

Authors: Thomas Grüter, Volker Behrendt, Corinna I. Bien, Ralf Gold, Ilya Ayzenberg

Excerpt

Dear Sirs, …

Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13(6):575–586. https://doi.org/10.1016/S1474-4422(14)70051-1 CrossRefPubMedPubMedCentral

Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88(18):1736–1743. https://doi.org/10.1212/WNL.0000000000003887 CrossRefPubMedPubMedCentral

Honorat JA, Komorowski L, Josephs KA et al (2017) IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm 4(5):e385. https://doi.org/10.1212/NXI.0000000000000385 CrossRefPubMedPubMedCentral

Haitao R, Yingmai Y, Yan H et al (2016) Chorea and Parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol 300:9–10. https://doi.org/10.1016/j.jneuroim.2016.09.012 CrossRefPubMed

Gaig C, Compta Y (2019) Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease. Curr Opin Neurol 32(3):493–499. https://doi.org/10.1097/WCO.0000000000000677 CrossRefPubMed

Moreno-Estébanez A, Garcia-Ormaechea M, Tijero B et al (2018) Anti-IgLON5 disease responsive to immunotherapy: a case report with an abnormal MRI. Mov Disord Clin Pract 5(6):653–656. https://doi.org/10.1002/mdc3.12679 CrossRefPubMedPubMedCentral

Montagna M, Amir R, de Volder I et al (2018) IgLON5-associated encephalitis with atypical brain magnetic resonance imaging and cerebrospinal fluid changes. Front Neurol 9:329. https://doi.org/10.3389/fneur.2018.00329 CrossRefPubMedPubMedCentral

Sabater L, Planagumà J, Dalmau J et al (2016) Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflamm 13(1):226. https://doi.org/10.1186/s12974-016-0689-1 CrossRef

Title: Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
Authors: Thomas Grüter
Volker Behrendt
Corinna I. Bien
Ralf Gold
Ilya Ayzenberg
Publication date: 01-07-2020
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 7/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09924-y